BLCOBausch + Lomb Corp.
$16.16
$0.18
(1.13%)
EarningsJul 29
Mkt Cap$5.7B
Vol338,512.00
Bausch + Lomb Launches EyeGility Inserter for enVista IOLs in the U.S.
BLCO launches EyeGility in the United States, pairing preloaded enVista Aspire lenses with smoother handling, one-handed use and surgical flexibility.
Zacks
Bausch + Lomb Launches EyeGility Inserter Preloaded IOL Delivery System in the United States
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of the EyeGility Inserter preloaded IOL delivery system. This press release features multimedia. View the full release here...
Business Wire
Bausch + Lomb Ends Glaucoma Drug Development, Shifts Focus
Bausch + Lomb ended BL1107 glaucoma eye drop development after a Phase 2 miss and will focus on a sustained-release GA implant.read more...
Benzinga
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced topline results from its Phase 2 study evaluating BL1107 in patients with glaucoma. The study did not achieve its primary endpoint of replicating...
Business Wire
Bausch + Lomb Introduces Orphia, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the creation of Orphia, a new AI-powered digital health platform built on the belief that eye care providers should spend less time managing...
Business Wire
Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter financial results on Wednesday, July 29, 2026. The company will host a conference call and live webcast at 8 a.m. ET to discuss the...
Business Wire
New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced new findings from its third annual State of Dry Eye survey, which reveals that the impact of dry eye can extend beyond the burden of physical...
Business Wire
Is COO Stock Attractive as MyDay Gains Meet Asia-Pacific Pressure
COO's MyDay, MiSight and fertility strengths support the long-term case, but Asia-Pacific softness, recall costs and leverage keep the stock in wait-and-see mode.
Zacks
How COO Is Balancing Premium Lens Growth Against Asia-Pacific Risks?
COO's premium lens, myopia control and fertility momentum support growth, but Asia-Pacific weakness and margin pressure keep the outlook measured.
Zacks
<
1
2
...
>
Advertisement|Remove ads.
HIMS2
2
SPY20
38HIMS5
2Advertisement|Remove ads.